13F Holdings
中文EN

TFX TELEFLEX INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 96943 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.9%
TTM net income YoY192.9%
TTM EPS YoY212.3%
Revenue 3-yr CAGR-8.6%
Net income 3-yr CAGR-9.0%

Margins

Gross margin58.3%
Operating margin9.4%
Net margin13.5%
FCF margin3.9%
EBITDA margin18.7%

Returns

ROE8.3%
ROA4.3%
ROIC (approx.)3.8%
Asset turnover0.32x

Leverage & solvency

Liabilities / assets45.0%
Debt / equity0.46x
Current ratio2.01x
Interest coverage2.06x

Cash quality & payout

Operating cash flow / net income0.47x
Accruals ratio2.3%
Payout ratio19.3%
Capex / revenue2.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.99B$1.70B$1.71B$2.79B$2.81B
Cost of revenue$871.96M$662.16M$672.33M$1.26B$1.26B
Gross profit$1.12B$1.04B$1.04B$1.53B$1.55B
R&D expense$144.78M$109.02M$113.63M$153.82M$130.84M
SG&A expense$720.17M$674.52M$622.74M$863.75M$860.09M
Operating income$118.37M$103.65M$258.73M$499.73M$628.10M
Interest expense$100.22M$83.51M$85.01M$54.26M$56.97M
Pretax income$24.55M$26.29M$185.39M$445.92M$559.47M
Income tax-$33.98M-$30.90M$41.87M$83.00M$74.35M
Net income-$905.64M$69.67M$356.33M$363.14M$485.37M
EBITDA$296.11M$265.19M$406.83M$730.32M$865.46M
EPS (basic)-20.301.497.587.7410.38
EPS (diluted)-20.251.487.537.6810.23
Dividends declared per share1.361.361.361.361.36
Weighted avg. shares (diluted)44.72M47.09M47.30M47.31M47.43M
Balance sheet
Cash & equivalents$378.56M$247.85M$222.85M$292.03M$445.08M
Receivables$345.58M$226.73M$443.47M$408.83M$383.57M
Inventory$404.39M$306.77M$626.22M$578.51M$477.64M
Current assets$1.94B$1.47B$1.41B$1.41B$1.43B
PP&E, net$498.28M$308.46M$479.91M$447.20M$443.76M
Goodwill$2.31B$1.99B$2.91B$2.54B$2.50B
Intangibles$1.52B$1.35B$2.50B$2.31B$2.29B
Total assets$6.95B$7.10B$7.53B$6.93B$6.87B
Current liabilities$762.03M$649.36M$606.75M$581.49M$680.12M
Short-term debt$100.00M$100.00M$87.50M$87.50M$110.00M
Long-term debt$2.54B$1.56B$1.73B$1.62B$1.74B
Total debt$2.64B$1.66B$1.82B$1.71B$1.85B
Total liabilities$3.82B$2.82B$3.09B$2.91B$3.12B
Shareholders' equity$3.12B$4.28B$4.44B$4.02B$3.75B
Net debt$2.26B$1.41B$1.59B$1.42B$1.41B
Cash flow statement
Operating cash flow$96.68M$301.88M$206.14M$342.81M$652.14M
Capital expenditure$95.24M$90.44M$46.42M$79.19M$71.62M
Free cash flow$1.45M$211.44M$159.72M$263.62M$580.52M
Investing cash flow-$812.65M-$63.36M$27.26M-$259.41M$156.74M
Financing cash flow$611.54M-$421.93M$38.54M-$217.51M-$715.82M
Depreciation & amortization$177.74M$161.53M$148.10M$230.59M$237.36M
Stock-based compensation$25.70M$25.96M$27.30M$27.22M$22.94M
Dividends paid$60.27M$63.54M$63.90M$63.79M$63.65M
Share buybacks$300.00M$200.00M$0$0—

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.